Terms: = Cervical cancer AND ERBB2, c-erb B2, 2064, P04626, ENSG00000141736, c-erbB2, HER-2/neu, HER2, TKR1, NEU, NGL, HER-2 AND Prognosis
66 results:
1. Targeting her2-mutant metastatic cervical cancer with neratinib: Final results from the phase 2 SUMMIT basket trial.
Friedman CF; D'Souza A; Bello Roufai D; Tinker AV; de Miguel M; Gambardella V; Goldman J; Loi S; Melisko ME; Oaknin A; Spanggaard I; Shapiro GI; ElNaggar AC; Panni S; Ravichandran V; Frazier AL; DiPrimeo D; Eli LD; Solit DB
Gynecol Oncol; 2024 Feb; 181():162-169. PubMed ID: 38211393
[TBL] [Abstract] [Full Text] [Related]
2. Invasive stratified mucin-producing carcinoma (ISMC) of the cervix: a clinicopathological and molecular analysis of 59 cases with special emphasis on histogenesis and potential therapeutic targets.
Yao Y; Wang Y; Ye L; Lu B; Lu W
Histopathology; 2024 Jan; 84(2):315-324. PubMed ID: 37735961
[TBL] [Abstract] [Full Text] [Related]
3. Establishment of a high-fidelity patient-derived xenograft model for cervical cancer enables the evaluation of patient's response to conventional and novel therapies.
Liu L; Wu M; Huang A; Gao C; Yang Y; Liu H; Jiang H; Yu L; Huang Y; Wang H
J Transl Med; 2023 Sep; 21(1):611. PubMed ID: 37689699
[TBL] [Abstract] [Full Text] [Related]
4. Epidemiology of cervical cancer in elderly women: Analysis of incidence, treatment, and survival using German registry data.
Neumeyer S; Tanaka LF; Liang LA; Klug SJ
Cancer Med; 2023 Aug; 12(16):17284-17295. PubMed ID: 37403686
[TBL] [Abstract] [Full Text] [Related]
5. The differences in immune features and genomic profiling between squamous cell carcinoma and adenocarcinoma - A multi-center study in Chinese patients with uterine cervical cancer.
Li J; Xue X; Zhang Y; Ding F; Wu W; Liu C; Xu Y; Chen H; Ou Q; Shao Y; Li X; Wu F; Wu X
Gynecol Oncol; 2023 Aug; 175():133-141. PubMed ID: 37356314
[TBL] [Abstract] [Full Text] [Related]
6. Involvement in Tumorigenesis and Clinical Significance of CXCL1 in Reproductive cancers: Breast cancer, cervical cancer, Endometrial cancer, Ovarian cancer and Prostate cancer.
Korbecki J; Bosiacki M; Barczak K; Łagocka R; Brodowska A; Chlubek D; Baranowska-Bosiacka I
Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108425
[TBL] [Abstract] [Full Text] [Related]
7. Mixed mucinous adenocarcinoma/large cell neuroendocrine carcinoma of the uterine cervix: case report and molecular characterization of a rare entity.
Fattorini C; Rocca BJ; Giusti A; Arganini M; Perotti B; Cavazzana A; Ambrosio MR; Volante M
Virchows Arch; 2024 Jan; 484(1):141-146. PubMed ID: 36988712
[TBL] [Abstract] [Full Text] [Related]
8. Oligometastatic breast cancer to parotid gland with complete response.
Peron V; Miyasaki Piovesana M; Martins Medeiros E; André Di Ricco B; Teixeira Liutti V
Breast Dis; 2023; 42(1):67-71. PubMed ID: 36911926
[TBL] [Abstract] [Full Text] [Related]
9. Assessment of her2 in Gastric-Type Endocervical Adenocarcinoma and its Prognostic Significance.
Wang S; Zhou X; Niu S; Chen L; Zhang H; Chen H; Zhou F
Mod Pathol; 2023 Jun; 36(6):100148. PubMed ID: 36841435
[TBL] [Abstract] [Full Text] [Related]
10. Investigational drugs for recurrent or primary advanced metastatic cervical cancer: what is in the clinical development pipeline?
Vergote I; Ray-Coquard I; Lorusso D; Oaknin A; Cibula D; Van Gorp T
Expert Opin Investig Drugs; 2023 Mar; 32(3):201-211. PubMed ID: 36803278
[TBL] [Abstract] [Full Text] [Related]
11. Adenoid Basal Carcinoma with Adenoid Cystic Carcinoma Component of the Uterine Cervix: A Case Report and Literature Review.
Kitamura SI; Yoshida H; Kobayashi-Kato M; Kikkawa N; Tanase Y; Uno M; Ishikawa M; Kato T
Int J Surg Pathol; 2023 Aug; 31(5):819-824. PubMed ID: 36452999
[TBL] [Abstract] [Full Text] [Related]
12. Morphologic and Molecular Heterogeneity of cervical neuroendocrine Neoplasia: A Report of 14 Cases.
Ordulu Z; Mino-Kenudson M; Young RH; Van de Vijver K; Zannoni GF; Félix A; Burandt E; Wong A; Nardi V; Oliva E
Am J Surg Pathol; 2022 Dec; 46(12):1670-1681. PubMed ID: 36069807
[TBL] [Abstract] [Full Text] [Related]
13. Association of recurrent APOBEC3B alterations with the prognosis of gastric-type cervical adenocarcinoma.
Liao X; Xia X; Su W; Yan H; Ma Y; Xu L; Luo H; Liu W; Yin D; Zhang WH; Chen HN; Deng Y; Ren Z; Yu Z; Liao F; Chen K; Cao M; Zhang Y; Zhang W; Wang W; Zhao JN; Xu H; Shu Y
Gynecol Oncol; 2022 Apr; 165(1):105-113. PubMed ID: 35151492
[TBL] [Abstract] [Full Text] [Related]
14. Driver gene mutations in micro-invasive cervical squamous cancers have no prognostic significance.
Kashofer K; Regauer S; Reich O; Petru E; Winter E
Gynecol Oncol; 2022 Apr; 165(1):121-128. PubMed ID: 35101299
[TBL] [Abstract] [Full Text] [Related]
15. Immunohistochemistry in gynecologic carcinomas: Practical update with diagnostic and clinical considerations based on the 2020 WHO classification of tumors.
Buza N
Semin Diagn Pathol; 2022 Jan; 39(1):58-77. PubMed ID: 34750021
[TBL] [Abstract] [Full Text] [Related]
16. Review of tumor infiltrating lymphocytes assessment in breast cancer in routine diagnostic practice.
Dundr P; Gregová M; Bártů M; Zimovjanová M; Petruželka L; Bielčiková Z; Fabian P; Matěj R; Ryška A; Němejcová K
Cesk Patol; 2021; 57(3):161-166. PubMed ID: 34551565
[TBL] [Abstract] [Full Text] [Related]
17. Value of metabolic parameters of primary lesions examined by 18F-FDG PET/CT for endometrial cancer in preoperative evaluation.
Gai QZ; Lv YB; Li GY; Zhang DQ; Gao Z; Fang XH
Eur Rev Med Pharmacol Sci; 2021 Mar; 25(6):2493-2502. PubMed ID: 33829435
[TBL] [Abstract] [Full Text] [Related]
18. Comprehensive genomic profiling and prognostic analysis of cervical gastric-type mucinous adenocarcinoma.
Lu S; Shi J; Zhang X; Kong F; Liu L; Dong X; Wang K; Shen D
Virchows Arch; 2021 Nov; 479(5):893-903. PubMed ID: 33817764
[TBL] [Abstract] [Full Text] [Related]
19. An analysis of her2 amplification in cervical adenocarcinoma: correlation with clinical outcomes and the International Endocervical Adenocarcinoma Criteria and Classification.
Shi H; Shao Y; Lu W; Lu B
J Pathol Clin Res; 2021 Jan; 7(1):86-95. PubMed ID: 33089969
[TBL] [Abstract] [Full Text] [Related]
20. miRNA Expression Profiles in Luminal A Breast cancer-Implications in Biology, prognosis, and Prediction of Response to Hormonal Treatment.
Kudela E; Samec M; Koklesova L; Liskova A; Kubatka P; Kozubik E; Rokos T; Pribulova T; Gabonova E; Smolar M; Biringer K
Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33080858
[TBL] [Abstract] [Full Text] [Related]
[Next]
